Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Open Studies | "Hand, Foot and Mouth Disease"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months
Condition: Hand Foot and Mouth Disease
Interventions: Biological: the first batch vaccine;   Biological: the second batch vaccine;   Biological: the third batch vaccine
2 Recruiting Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Condition: Handfoot-mouth Disease
Interventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid;   Drug: Ribavirin

Study has passed its completion date and status has not been verified in more than two years.